Research and Discoveries

Researchers from the University of Chicago and the University of Pittsburgh have identified a novel oncometabolite that accumulates in tumors and impairs immune cells’ ability to fight cancer.

Clinical trial results indicate that primary progressive aphasia (PPA) patients and their communication partners benefit from remote speech-language therapy.

Study in mice helps explain the mechanisms by which nitrous oxide affects the brain, potentially offering insights that could help relieve treatment-resistant depression.

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary glands with few treatment options. The study found that blocking the activity of protein arginine methyl transferase 5 (PRMT5) is a potential treatment strategy against ACC.

Chemotherapy and immunotherapy followed by de-escalated chemoradiation showed increased survival and reduced side effects in aggressive head and neck cancers that are not associated with human papillomavirus (HPV) infection, according to a new study.

With participants ages 80 to 110, the SuperAging Research Initiative examines what's going right in the lives and brains of people who are living long and living well.

New research shows that triple-negative breast cancer (TNBC) patients who are Black or have lower socioeconomic status are significantly less likely to have access to cutting-edge, life-saving treatments.

Combining bupropion medication and a behavioral counseling program dramatically increased quit rates among people living with HIV who smoked.